Researchers have developed a new blood test that can identify cancer in the body as part of a National Health Service (NHS) ...

Doctors can accurately predict a person's risk of fatty liver disease as early as 16 years before symptoms develop, a new ...

Marisa Peters experienced blood in her stool and an urgency to go starting at 33. At 39, she learned she had Stage 3 ...

Among patients with oncogene-driven advanced NSCLC who were treated with TKIs, ctDNA clearance was associated with improved survival end points.

A number of the Dutch firm's products have received certification under Europe's In Vitro Diagnostic Regulation recently.

The 35-year-old left-hander always flashes back to losing his dad to colon cancer at the start of his sophomore year at his ...

Researchers have developed a personalized blood test that may offer a faster, less invasive way to track high-grade glioma progression.

Guardant Health partners with Pfizer to support oncology drug development using smart liquid biopsy tech and expand testing access in China.

Mayo Clinic researchers have identified a potential new way to monitor the progression of high-grade gliomas, one of the most ...

EvoLiver, a blood test that detects early-stage liver cancer with high accuracy, has gained breakthrough device designation from the FDA.

Using the Ultima Genomics’ (CA, USA) lower-cost WGS platform and the known mutational patterns in patient tumors as a guide, ...

An AI-powered blood test for detecting 12 common cancers has been awarded government funding for further clinical trials.